Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Hydration Pharmaceuticals Co. Ltd. ( (AU:HPC) ) has shared an update.
Hydration Pharmaceuticals Co. Ltd. has issued 65,000,000 fully paid ordinary shares at $0.01 each to sophisticated and professional investors, as part of a placement announced earlier in March 2025. This move, conducted without disclosure to investors under Part 6D.2 of the Corporations Act, indicates the company’s compliance with relevant legal provisions and suggests a strategic effort to raise capital, potentially impacting its market positioning and stakeholder interests.
More about Hydration Pharmaceuticals Co. Ltd.
The Hydration Pharmaceuticals Company Limited, trading as Hydralyte USA, operates in the hydration solutions industry, focusing on providing hydration products. The company is listed on the Australian Securities Exchange under the ticker HPC.
YTD Price Performance: -50.0%
Average Trading Volume: 430,857
Technical Sentiment Signal: Buy
For an in-depth examination of HPC stock, go to TipRanks’ Stock Analysis page.